# Assessment of Inflammatory Biomarkers Expressed in a Sjogren's Population: Effect of a Topical Steroid Intervention

> **NCT00631358** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 97 (actual)

## Conditions studied

- Sjogren's Syndrome

## Interventions

- **DRUG:** Maxidex
- **OTHER:** No treatment

## Key facts

- **NCT ID:** NCT00631358
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-02
- **Final completion:** —
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2010-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00631358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00631358, "Assessment of Inflammatory Biomarkers Expressed in a Sjogren's Population: Effect of a Topical Steroid Intervention". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00631358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*